Yasuo Terauchi

1994–2025 年に発表

108
論文数
28,477
被引用数
67
h 指数
104
i10 指数

被引用数

Yasuo Terauchi の年別被引用数1989 年: 被引用 1 件1992 年: 被引用 4 件1994 年: 被引用 3 件1995 年: 被引用 17 件1996 年: 被引用 28 件1997 年: 被引用 29 件1998 年: 被引用 31 件1999 年: 被引用 56 件2000 年: 被引用 123 件2001 年: 被引用 149 件2002 年: 被引用 312 件2003 年: 被引用 408 件2004 年: 被引用 534 件2005 年: 被引用 592 件2006 年: 被引用 502 件2007 年: 被引用 505 件2008 年: 被引用 468 件2009 年: 被引用 353 件2010 年: 被引用 352 件2011 年: 被引用 322 件2012 年: 被引用 270 件2013 年: 被引用 316 件2014 年: 被引用 215 件2015 年: 被引用 224 件2016 年: 被引用 207 件2017 年: 被引用 194 件2018 年: 被引用 193 件2019 年: 被引用 638 件2020 年: 被引用 617 件2021 年: 被引用 579 件2022 年: 被引用 408 件2023 年: 被引用 351 件2024 年: 被引用 478 件2025 年: 被引用 246 件2026 年: 被引用 8 件1990〜1991 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,148 件、この内訳の 28.7%日本: 引用元論文 1,046 件、この内訳の 9.5%中国: 引用元論文 908 件、この内訳の 8.3%イギリス: 引用元論文 644 件、この内訳の 5.9%イタリア: 引用元論文 422 件、この内訳の 3.8%ドイツ: 引用元論文 387 件、この内訳の 3.5%フランス: 引用元論文 383 件、この内訳の 3.5%カナダ: 引用元論文 363 件、この内訳の 3.3%韓国: 引用元論文 295 件、この内訳の 2.7%オーストラリア: 引用元論文 265 件、この内訳の 2.4%スペイン: 引用元論文 233 件、この内訳の 2.1%インド: 引用元論文 233 件、この内訳の 2.1%
0%28.7%その他 24.2%

分野

  • Medicine64.5%
  • Biochemistry, Genetics and Molecular Biology23.9%
  • Immunology and Microbiology4.3%
  • Neuroscience3.9%
  • Nursing0.9%
  • Agricultural and Biological Sciences0.6%
  • その他1.9%

トピック

  • Adipokines, Inflammation, and Metabolic Diseases9.9%
  • Adipose Tissue and Metabolism8.4%
  • Metabolism, Diabetes, and Cancer4.9%
  • Pancreatic function and diabetes3.6%
  • Diabetes Treatment and Management3.4%
  • Regulation of Appetite and Obesity3.3%
  • その他66.5%

共著者

全論文

検索で開く
  1. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Ortiz, Enrique Villegas, Albina Golovach, Diana Alpenidze, Elena Frolova, Elena Zhdanova, Ludmila Ruyatkina, О. Б. Ершова, Ю. Г. Самойлова, S. T. Zyangirova, Katarina Lalić, Nebojša Lalić, Teodora Beljić Živković, Hayriye Esra Ataoğlu, Okan Bakıner, A. D. Dayan, Mehmet Sargın, Meral Mert, Mine Adaş, Ömür Tabak, Yüksel Altuntaş, Alexander V. Murray, Ali Iranmanesh, Aron Schlau, Bram Wieskopf, Brian D. Snyder, Carl J. Griffin, Charles Fogarty, Charles Lovell, Dale Allison, David Fitzpatrick, David Grant, David C. Klonoff, Dwayne Williams, Eddie Armas, Eileen M. Palace, Gary Ruoff, Gilbert Martinez, Gilberto Perez, Harold Bays, Horia Tatu, James Maynard, Jeanne-Elyse Cedeno, Vanita R. Aroda, Jean Park, Jennefer Sutton, Joe Pouzar, John Bertsch, Jonathan Condit, Jorge Serje, Josel Cabaccan, Joseph Risser, Juan P. Frías, Julio Rosenstock, Kanagaratnam Sivalingam, Kelli Maw, Lenita Hanson, Liana K. Billings, Lisa Connery, Mario Juarez, Michael Lillestol, Neil Fraser, Paul Beckett, Ralph Wade, Raul Gaona, Richard F. W. Jackson, Robert DeLuca, Sady Alpizar, Sharon J. Herring, Stanley Stringam ほか 5 名 - Diabetes Care 2019 被引用: 468

  2. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2001 被引用: 4,917

  3. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2003 被引用: 3,185

  4. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , San‐e Ishikawa, Masafumi Kakei, Kazuyuki Namai, Naotake Hashimoto, Yoshifumi Suzuki, Shunichiro Onishi, Koutaro Yokote, Masafumi Matsuda, Masahiro Masuzawa, Yoichi Hayashi, Satoshi Saitô, Norikazu Ogihara, Hisamitsu Ishihara, Naoko Tajima, Kazunori Utsunomiya, Akira Shimada, Hiroshi Itoh, Ryuzo Kawamori, Hirotaka Watada, Michio Hayashi, Yasumichi Mori, Teruo Shiba, Akihiro Isogawa, Hiroshi Sakura, Masato Odawara, Kazuyuki Tobe, Kazuhisa Tsukamoto, Toshimasa Yamauchi, Tamio Teramoto, Yukio Hirata, Isao UCHIMURA, Yoshihiro Ogawa, Gen Yoshino, Takahisa Hirose, Hiroshi Kajio, Yoshihito Atsumi, Akira Shimada, Yoichi Oikawa, Atsushi Araki, Akio Ueki, Atsushi Ohno, Masafumi Kitaoka, Yoshikuni Fujita, Tatsumi Moriya, Taiki Tojo, Masayoshi Shichiri, Daisuke Suzuki, Masao Toyoda, Kumiko Hamano, Rieko Komi, Yasuo Terauchi, Nobuaki Kuzuya, Masayo Yamada, Toshinari Takamura, Mitsuo Imura, Hiroshi Tanaka, Masayuki Hayashi, Yasuhisa Kato, Mitsuyasu Itoh, Atsushi Suzuki, Mikihiro Nakayama, Takahisa Sano, Eitaro Nakashima, Yasuhiro Sumida, Yutaka Yano, Tsuyoshi Tanaka, Kazuya Murata, Atsunori Kashiwagi, Hiroshi Maegawa, Shigeo Kono ほか 57 名 - The Lancet Diabetes & Endocrinology 2017 被引用: 309

  5. Adiponectin Stimulates AMP-Activated Protein Kinase in the Hypothalamus and Increases Food Intake

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2007 被引用: 837

  6. PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cell 1999 被引用: 1,353

  7. Role of Altered Renal Lipid Metabolism in the Development of Renal Injury Induced by a High-Fat Diet

    著者: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2007 被引用: 281

  8. Imeglimin Ameliorates β-Cell Apoptosis by Modulating the Endoplasmic Reticulum Homeostasis Pathway

    著者: , , , , , , , , , , , , , , , - Diabetes 2021 被引用: 74

  9. Impaired Insulin Signaling in Endothelial Cells Reduces Insulin-Induced Glucose Uptake by Skeletal Muscle

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasuo Terauchi, Kazuyuki Tobe, Ryozo Nagai, Katsuo Kamata, Kenji Inoue, Tatsuhiko Kodama, Kohjiro Ueki, Takashi Kadowaki - Cell Metabolism 2011 被引用: 436

  10. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity

    著者: , , , , , , , , , , , , , , , , , - Nature Communications 2016 被引用: 132

  11. Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in J apanese people with type 2 diabetes

    著者: , , , , , , , - Diabetes Obesity and Metabolism 2017 被引用: 121

  12. Role of NADH Shuttle System in Glucose-Induced Activation of Mitochondrial Metabolism and Insulin Secretion

    著者: , , , , , , , , , , , , , , - Science 1999 被引用: 493

  13. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis

    著者: , , , , - BMJ 2013 被引用: 493

  14. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

    著者: , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2007 被引用: 293

  15. Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial

    著者: , , , - Journal of Diabetes Investigation 2023 被引用: 19

  16. Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2004 被引用: 547

  17. Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masato Kasuga, Michihiro Matsumoto - JCI Insight 2023 被引用: 38

  18. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1

    著者: , , , , , , , , , , , , , , , , , - Nature 1994 被引用: 1,088

  19. Lessons from Mouse Models of High-Fat Diet-Induced NAFLD

    著者: , - International Journal of Molecular Sciences 2013 被引用: 188

  20. Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26‐week, open‐label, multicentre study: The LixiLan JP‐O2 randomized clinical trial

    著者: , , , , , - Diabetes Obesity and Metabolism 2020 被引用: 37

  21. Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation

    著者: , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2002 被引用: 1,209

  22. PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

    著者: , , , , , , , , , , , - Journal of Clinical Investigation 2004 被引用: 786

  23. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.

    著者: , , , , , , , , , , , , , , , , , , , - Diabetes 2000 被引用: 527

  24. Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2006 被引用: 327